Williams BG

The multi-wave skew-logistic process applied to the UK COVID-19 pandemic and being carbon negative in climate change
Cheng R, Williams BG

Archives of Clinical and Biomedical Research

(2024)

https://doi.org/10.26502/acbr.50170412
Modelling presymptomatic Infectiousness in COVID-19
Cheng R, Dye C, Dagpunar JS, Williams BG

Journal of Simulation

(2023)

https://doi.org/10.1080/17477778.2023.2190467
Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa
Granich R, Gupta S, Williams BG

International Journal of STD & AIDS

(2022)

https://doi.org/10.1177/09564624211042287
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data
Ross JM, Badje A, Rangaka MX, Walker AS, Shapiro AE, Thomas KK, Anglaret X, Eholie S, Gabillard D, Boulle A, Maartens G, Wilkinson RJ, Ford N, Golub JE, Williams BG, Barnabas RV

The Lancet HIV

(2021)

https://doi.org/10.1016/s2352-3018(20)30299-x
The scale and dynamics of COVID-19 epidemics across Europe
Dye C, Cheng RCH, Dagpunar JS, Williams BG

Royal Society Open Science

(2020)

https://doi.org/10.1098/rsos.201726
Treatment as prevention trials and ending AIDS: what do we know when did we know it, and what did we do?
Granich R, Williams BG

Current Opinion in HIV and AIDS

(2019)

https://doi.org/10.1097/COH.0000000000000582
HIV control strategies for sex worker-client contact networks
Mulberry N, Rutherford AR, Wittenberg RW, Williams BG

Journal of the Royal Society Interface

(2019)

https://doi.org/10.1098/rsif.2019.0497
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis
Phillips AN, Cambiano V, Nakagawa F, Matharu LB, Wilson D, Jani I, Apollo T, Sculpher M, Hallett TB, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams BG, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas RV, Ayles H, Rath GM, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P

Journal of the International AIDS Society

(2019)

https://doi.org/10.1002/jia2.25325
Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region
Dye C, Williams BG

Bulletin of The World Health Organization

(2019)

https://doi.org/10.2471/BLT.18.228577
HIV-attributable causes of death in the medical ward at the Chris Hani Baragwanath Hospital, South Africa
Black A, Sitas F, Chibawara T, Gill Z, Kubanje M, Williams BG

PLoS One

(2019)

https://doi.org/10.1371/journal.pone.0215591
African voices and leadership is imperative for the global AIDS response
Mbopi-Keou F-X, Williams BG, Belec L, Kalla GCM, Ndoye I, Konate MH, Mensah TG

The Pan African Medical Journal

(2019)

https://doi.org/10.11604/pamj.2019.32.87.18452
Global and regional molecular epidemiology of HIV-1, 1990 to 2015: a systematic review, global survey, and trend analysis
Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams BG, Gouws E, Ghys P

The Lancet Infectious Diseases

(2019)

https://doi.org/10.1016/S1473-3099(18)30647-9
Questionable assumptions mar modelling of Kenya home-based testing campaigns
Granich R, Gupta S, Williams BG

Journal of the International AIDS Society

(2019)

https://doi.org/10.1002/jia2.25230
Modeling the HIV Epidemic: Why the 95-95-95 Target and ART Effectiveness Parameters Matter
Granich R, Gupta S, Wollmers M, Ruffner M, Williams BG

International Journal of Virology and AIDS

(2018)

https://doi.org/10.23937/2469-567X/1510041
90-90-90, epidemic control and ending AIDS: global situation and recommendations
Granich R, Gupta S, Williams BG

International Journal of Virology and AIDS

(2018)

https://doi.org/10.23937/2469-567X/1510043
Epidemiological metrics and benchmarks for a transition in the HIV epidemic
Ghys P, Williams BG, Over M, Hallett TB, Godfrey-Faussett P

PLoS Medicine

(2018)

https://doi.org/10.1371/journal.pmed.1002678
HIV, 95-95-95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective
Granich R, Gupta S, Williams BG

Journal of the International AIDS Society

(2018)

https://doi.org/10.1002/jia2.25191
Tuberculosis control: recalling past insights
Williams BG

The Lancet

(2018)

https://doi.org/10.1016/S2214-109X(18)30343-7
A signature for biological heterogeneity in susceptibility to HIV infection?
Nagelkerke N, Abu-Raddad LJ, Awad SF, Black V, Williams BG

Infectious Disease Modelling

(2018)

https://doi.org/10.1016/j.idm.2018.08.002
What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study
Garcia-Basteiro AL, Brew J, Williams BG, Borgdorff M, Cobelens F.

International Journal of Epidemiology

(2018)

https://doi.org/10.1093/ije/dyy144
Dynamics and control of infections on social networks of population types
Williams BG, Dye C

Epidemics

(2018)

https://doi.org/10.1016/j.epidem.2017.10.002
High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV tests in the Tshwane District of South Africa – the importance of behavioural prevention measures
Mayaphi SH, Martin DJ, Olorunju SAS, Williams BG, Stoltz AC

PLOS ONE

(2018)

https://doi.org/10.1371/journal.pone.0192357
Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how?
Beck EJ, Tanna G, Vega IDE, Arews G, Bocher P, Garcia Calleja JM, Cutler J, Ewing W, Mahy M, Makofane K, Marsh K, Sabin K, Williams BG, Nunez C, Ghys P, Low-Beer D

Global Health Action

(2018)

https://doi.org/10.1080/16549716.2018.1440782
Ending AIDS: myth or reality?
Williams BG, Granich R

The Lancet

(2017)

https://doi.org/10.1016/S0140-6736(17)31832-9
90-90-90 and ending AIDS: necessary and feasible
Granich R, Williams BG, Montaner J, Zuniga JM

The Lancet

(2017)

https://doi.org/10.1016/S0140-6736(17)31872-X

12 Next

Williams BG

The multi-wave skew-logistic process applied to the UK COVID-19 pandemic and being carbon negative in climate change

Modelling presymptomatic Infectiousness in COVID-19

Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa

Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data

The scale and dynamics of COVID-19 epidemics across Europe

Treatment as prevention trials and ending AIDS: what do we know when did we know it, and what did we do?

HIV control strategies for sex worker-client contact networks

Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis

Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region

HIV-attributable causes of death in the medical ward at the Chris Hani Baragwanath Hospital, South Africa

African voices and leadership is imperative for the global AIDS response

Global and regional molecular epidemiology of HIV-1, 1990 to 2015: a systematic review, global survey, and trend analysis

Questionable assumptions mar modelling of Kenya home-based testing campaigns

Modeling the HIV Epidemic: Why the 95-95-95 Target and ART Effectiveness Parameters Matter

90-90-90, epidemic control and ending AIDS: global situation and recommendations

Epidemiological metrics and benchmarks for a transition in the HIV epidemic

HIV, 95-95-95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective

Tuberculosis control: recalling past insights

A signature for biological heterogeneity in susceptibility to HIV infection?

What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study

Dynamics and control of infections on social networks of population types

High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV tests in the Tshwane District of South Africa – the importance of behavioural prevention measures

Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how?

Ending AIDS: myth or reality?

90-90-90 and ending AIDS: necessary and feasible

Type

Year

Author